Henry Schein Inc.
HSIC
Get informed when a big investor buys or sells
+ Follow
Current Fair Value
4.6% downsideOvervalued by 4.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.72 Billion |
|---|---|
| Enterprise Value | $12.33 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.29 |
| Beta | 0.82 |
| Outstanding Shares | 114,939,640 |
Return
| Return on Equity | 12.09% |
|---|---|
| Return on Assets | 3.49% |
| Return on Invested Capital | 8.99% |
Valuation & Multiples
| P/E Ratio | 22.28 |
|---|---|
| PEG | -817.07 |
| Price to Sales | 0.65 |
| Price to Book Ratio | 1.85 |
| Enterprise Value to Revenue | 0.92 |
| Enterprise Value to EBIT | 17.13 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 1.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1450▼ 8.29% |
|---|---|
| Total Calls | 495,300▼ 56.21% |
| Total Puts | 71,800▼ 72.14% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 102.49%▲ 1.85% |
|---|---|
| Total Invested | $8.87B▼ 3.11% |
| Investors Holding | 5630% |
ESG Score
No data
About Henry Schein Inc.
19,000 employees
CEO: Stanley Bergman Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 mi...
Relevant Senate Committees
This committee provides critical analysis and official revenue estimates for tax legislation. Its work directly shapes corporate tax structures and capital investment incentives, significantly impacting Henry Schein's financial planning and corporate profitability as a large enterprise.
This committee controls taxation, trade, and entitlement spending. Tax policy directly impacts Henry Schein's profitability, trade policy affects its global supply chain, and Medicare/Medicaid pricing influences the financial health and purchasing power of its healthcare practitioner customers.
This committee directly allocates discretionary federal spending. For Henry Schein, this means direct control over the specific cash flow for government and institutional healthcare clinics, significantly impacting their purchasing power and Henry Schein's federal contract revenues.
This committee regulates the FDA, which oversees medical devices and supplies that Henry Schein distributes. It also influences labor laws, impacting the company's workforce costs, and affects funding for health initiatives that drive demand.
Henry Schein supplies 'government and institutional healthcare clinics.' This committee's funding decisions for the Department of Veterans Affairs (VA) directly impact a significant potential customer segment for Henry Schein's medical and dental supplies.